IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q3 2023 Holdings

Filed 2023-11-13 | 11 holdings | $87.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$40.5M7,044,50046.4%
Invivyd Inc(IVVD)COM00534A102$15.7M9,248,25018.0%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$10.7M523,28012.3%
Springworks Therapeutics IncCOM85205L107$4.6M197,7005.2%
Silence Therapeutics PLC(SLN)ADS82686Q101$3.6M363,8004.1%
Bridgebio Pharma Inc(BBIO)COM10806X102$3.2M121,2003.7%
Curis Inc(CRIS)COM NEW231269309$2.8M421,9513.2%
Proqr Thrapeutics N VSHS EURON71542109$2.5M1,910,6002.8%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.8M67,4002.1%
TG Therapeutics Inc(TGTX)COM88322Q108$1.8M216,6002.1%
Neximmune IncCOM65344D109$28.0K133,4420.0%